JPRN-UMIN000022348已完成2 期
Efficacy and safety of epicutaneous immunotherapy for severe egg allergy - Epicutaneous immunotherapy for egg allergy
ational Hospital Organization Mie National Hospital0 个研究点目标入组 40 人开始时间: 2016年5月24日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 4years-old 至 15years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Allergy to soy and milk 2) Large change in intake levels of egg before 3 months of the trial 3) Complication or past history of heart, liver and kidney diseases 4) Uncontrolled asthma or atopic dermatitis
研究者
相似试验
招募中
2 期
Epicutaneous Immunotherapy for Egg AllergyEgg allergyEgg allergy, epicutaneous immunotherapyJPRN-jRCTs031200307Iwai Fumiko63
已完成
2 期
Efficacy and safety of epicutaneous immunotherapy for severe milk allergyFood allergyJPRN-UMIN000024564ational Hospital Organization Mie National Hospital46
已完成
2 期
Efficacy and safety of epicutaneous immunotherapy for severe egg allergy; Long term trialFood allergyJPRN-UMIN000025381ational Hospital Organization Mie National Hospital20
已完成
2 期
Efficacy and safety of epicutaneous immunotherapy for severe milk allergy; Long term trialFood allergyJPRN-UMIN000027459ational Hospital Organization Mie National Hospital46
尚未招募
不适用
Efficacy of the epicutaneous immunotherapy for food allergy -Selection of skin sticking device and allergenmilk allergyJPRN-UMIN000037562Tokai University Hachioji Hospital40